Company / Cash per Share
CAPRICOR THERAPEUTICS, INC. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$5.02
FY2025
5-year range
$0.25 / $5.02
FY2021-FY2025
Trend
+1926.2%
vs FY2024
Sector context
#40 of 204
Health Care
What the data says
Cash per Share changed +1926% YoY in FY2025, a notable deviation from the 9-year average annual change of +297%.
Based on SEC 10-K filings.
5.02 in FY2025 with a 5-year CAGR of +25.9%. Top quartile in the Health Care sector.
Improved from $0.47 to $5.02 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +136.3%
- 5-Year CAGR
- +25.9%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 204This company $5.02 Sector average $73.19
▼
-93.1% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 1926.2% year-over-year.
- Ranks #40 out of 204 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.02 | +1926.2% |
| FY2024 | $0.25 | -47.5% |
| FY2023 | $0.47 | +24.0% |
| FY2022 | $0.38 | -73.6% |
| FY2021 | $1.44 | -9.1% |
| FY2020 | $1.59 | +27.8% |
| FY2019 | $1.24 | +815.5% |
| FY2018 | $0.14 | -41.9% |
| FY2017 | $0.23 | +56.1% |
| FY2016 | $0.15 | -56.3% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026